9999999997-18-000441.txt : 20180122 9999999997-18-000441.hdr.sgml : 20180122 20180122171552 ACCESSION NUMBER: 9999999997-18-000441 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180122 DATE AS OF CHANGE: 20180122 ACTION DATE: 20180122 RECEIVED DATE: 20180122 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DUSA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000879993 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223103129 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-31533 FILM NUMBER: 18540529 BUSINESS ADDRESS: STREET 1: 25 UPTON DRIVE CITY: WILMINGTON STATE: MA ZIP: 01887 BUSINESS PHONE: 9786577500 MAIL ADDRESS: STREET 1: 25 UPTON DRIVE CITY: WILMINGTON STATE: MA ZIP: 01887 FORMER COMPANY: FORMER CONFORMED NAME: DEPRENYL USA INC / NJ DATE OF NAME CHANGE: 19930328 CT ORDER 1 filename1.pdf begin 644 filename1.pdf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